288 related articles for article (PubMed ID: 24382812)
1. Albinterferon α2b adsorption to silicone oil-water interfaces: effects on protein conformation, aggregation, and subvisible particle formation.
Basu P; Blake-Haskins AW; O'Berry KB; Randolph TW; Carpenter JF
J Pharm Sci; 2014 Feb; 103(2):427-36. PubMed ID: 24382812
[TBL] [Abstract][Full Text] [Related]
2. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
[TBL] [Abstract][Full Text] [Related]
3. Demonstrating the stability of albinterferon alfa-2b in the presence of silicone oil.
Auge KB; Blake-Haskins AW; Devine S; Rizvi S; Li YM; Hesselberg M; Orvisky E; Affleck RP; Spitznagel TM; Perkins MD
J Pharm Sci; 2011 Dec; 100(12):5100-14. PubMed ID: 21780119
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
[TBL] [Abstract][Full Text] [Related]
5. Excipient effects on humanized monoclonal antibody interactions with silicone oil emulsions.
Britt KA; Schwartz DK; Wurth C; Mahler HC; Carpenter JF; Randolph TW
J Pharm Sci; 2012 Dec; 101(12):4419-32. PubMed ID: 22987313
[TBL] [Abstract][Full Text] [Related]
6. Protein adsorption and excipient effects on kinetic stability of silicone oil emulsions.
Ludwig DB; Carpenter JF; Hamel JB; Randolph TW
J Pharm Sci; 2010 Apr; 99(4):1721-33. PubMed ID: 19894257
[TBL] [Abstract][Full Text] [Related]
7. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
9. Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces.
Gerhardt A; Bonam K; Bee JS; Carpenter JF; Randolph TW
J Pharm Sci; 2013 Feb; 102(2):429-40. PubMed ID: 23212809
[TBL] [Abstract][Full Text] [Related]
10. Protein aggregation and particle formation in prefilled glass syringes.
Gerhardt A; Mcgraw NR; Schwartz DK; Bee JS; Carpenter JF; Randolph TW
J Pharm Sci; 2014 Jun; 103(6):1601-12. PubMed ID: 24729310
[TBL] [Abstract][Full Text] [Related]
11. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Structurally Perturbed Hen Egg Lysozyme Adsorbed to Silicone Oil Microdroplets in Wild-Type and Transgenic Mouse Models.
Chisholm CF; Soucie KR; Song JS; Strauch P; Torres RM; Carpenter JF; Ragheb JA; Randolph TW
J Pharm Sci; 2017 Jun; 106(6):1519-1527. PubMed ID: 28216023
[TBL] [Abstract][Full Text] [Related]
13. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
Teska BM; Brake JM; Tronto GS; Carpenter JF
J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
[TBL] [Abstract][Full Text] [Related]
14. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein Formulations.
Chisholm CF; Nguyen BH; Soucie KR; Torres RM; Carpenter JF; Randolph TW
J Pharm Sci; 2015 Nov; 104(11):3681-3690. PubMed ID: 26190624
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
[TBL] [Abstract][Full Text] [Related]
19. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.
Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF
J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229
[TBL] [Abstract][Full Text] [Related]
20. Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.
Thirumangalathu R; Krishnan S; Ricci MS; Brems DN; Randolph TW; Carpenter JF
J Pharm Sci; 2009 Sep; 98(9):3167-81. PubMed ID: 19360857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
